nymox pharmaceutical corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population. its lead drug candidate is fexapotide triflutate (nx-1207) that has completed phase iii clinical trials for the treatm

Nymox Pharmaceutical Corp

Sold all NYMX

This member connected a brokerage account and is sharing trades and portfolio performance with the community. 

Public Portfolio

Daniel Dallas

New position in NYMX

Sold $50k-$100k NYMX

This profile creates auto-generated trade alerts based on public disclosures.